Your session is about to expire
← Back to Search
Energy Delivery Device
Active for Osteopenia
N/A
Waitlist Available
Led By Laura Bilek, PT, PhD
Research Sponsored by Theranova, L.L.C.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Is able to provide informed consent
Female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This study is evaluating whether a belt which delivers energy to the skeleton may help reduce bone loss in postmenopausal women.
Eligible Conditions
- Osteopenia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of device-related adverse events present
Vertebral body strength
Secondary outcome measures
Femoral bone mineral density
Vertebral body bone mineral density
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Subjects in this group will receive the active treatment for each daily treatment session.
Group II: ShamPlacebo Group1 Intervention
Subjects in this group will receive the sham treatment for each daily treatment session.
Find a Location
Who is running the clinical trial?
Theranova, L.L.C.Lead Sponsor
11 Previous Clinical Trials
329 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,004,030 Total Patients Enrolled
University of NebraskaOTHER
533 Previous Clinical Trials
1,143,731 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New Jersey
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Share this study with friends
Copy Link
Messenger